Raul D. Santos
Raul D. Santos
University of Sao Paulo School of Medicine and Hospital Israelita Albert Einstein
E-mail confirmado em incor.usp.br
Título
Citado por
Citado por
Ano
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
22852013
V Brazilian guidelines on dyslipidemias and prevention of atherosclerosis
HT Xavier, MC Izar, JRF Neto, MH Assad, VZ Rocha, AC Sposito, ...
Arquivos brasileiros de cardiologia 101 (4 Suppl 1), 1-20, 2013
1657*2013
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management
ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ...
European heart journal 36 (17), 1012-1022, 2015
11172015
IV Brazilian Guideline for dyslipidemia and atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology
AC Sposito, B Caramelli, FAH Fonseca, MC Bertolami, AA Neto, ...
Arquivos brasileiros de cardiologia 88, 2-19, 2007
935*2007
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
893*2014
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised …
FJ Raal, RD Santos, DJ Blom, AD Marais, MJ Charng, WC Cromwell, ...
The Lancet 375 (9719), 998-1006, 2010
8902010
Update of the Brazilian directive on dyslipidemias and prevention of atherosclerosis-2017
AA Faludi, MCO Izar, JFK Saraiva, APM Chacra, HT Bianco, ...
ARQUIVOS BRASILEIROS DE CARDIOLOGIA 109 (2), 1-76, 2017
729*2017
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
6142015
Cardiovascular efficacy and safety of bococizumab in high-risk patients
PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ...
New England Journal of Medicine 376 (16), 1527-1539, 2017
5152017
The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association
SS Gidding, M Ann Champagne, SD de Ferranti, J Defesche, MK Ito, ...
Circulation 132 (22), 2167-2192, 2015
495*2015
First guidelines on fat consumption and cardiovascular health
RD Santos, ACM Gagliardi, HT Xavier, CD Magnoni, R Cassani, ...
Arquivos brasileiros de cardiologia 100 (1 Suppl 3), 1-40, 2013
459*2013
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ...
The lancet Diabetes & endocrinology 2 (8), 655-666, 2014
4492014
Uric acid: a marker of increased cardiovascular risk
ACM Gagliardi, MH Miname, RD Santos
Atherosclerosis 202 (1), 11-17, 2009
4482009
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ...
International journal of cardiology 171 (3), 309-325, 2014
4362014
Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment
FJ Raal, RD Santos
Atherosclerosis 223 (2), 262-268, 2012
3782012
Lipid Treatment Assessment Project 2 A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals
DD Waters, C Brotons, CW Chiang, J Ferrières, JA Foody, JW Jukema, ...
Circulation 120 (1), 28-34, 2009
3632009
I Brazilian guidelines on cardiovascular prevention
AF Simão, DB Precoma, JP Andrade, H Correa Filho, JFK Saraiva, ...
Arquivos brasileiros de cardiologia, 2013
344*2013
Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality--a systematic review
LL Roberson, EC Aneni, W Maziak, A Agatston, T Feldman, M Rouseff, ...
BMC public health 14 (1), 1-12, 2014
3112014
A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
ET Oni, AS Agatston, MJ Blaha, J Fialkow, R Cury, A Sposito, R Erbel, ...
Atherosclerosis 230 (2), 258-267, 2013
3042013
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe …
RD Santos, SS Gidding, RA Hegele, MA Cuchel, PJ Barter, GF Watts, ...
The lancet Diabetes & endocrinology 4 (10), 850-861, 2016
288*2016
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20